Overview
This series explains what human microplastic and nanoplastic findings can—and cannot—establish about health. It moves from detection and method limits through living-human associations, reproductive mechanisms, confounding and mixed exposures, to stronger study designs and proportionate prevention. The evidence supports real internal exposure and concerning signals, but not a settled individual risk, general disease burden, causal threshold, or proven treatment.
Learning outcomes
- MNPs have been detected in multiple human compartments, establishing internal exposure—not a diagnosis.
- Human studies report concerning associations, but most are observational, heterogeneous, and limited for causal inference.
- Cell and animal studies make particular harms plausible under defined conditions, not proven at ordinary human exposure.
- Source reduction and stronger safeguards can be proportionate while treatment, thresholds, and individual risk remain unsettled.
Keywords
Preview every chapter · Unlock full text, audio, and video from chapter 4
PlansFAQ
What does finding microplastics in the human body prove?
It establishes internal presence in the sampled material under stated analytical conditions; it does not by itself prove disease or causation.
Do human studies show that microplastics cause disease?
No, current human studies do not establish a general causal disease burden; most are observational, heterogeneous, or limited in timing and controls.
Why can laboratory evidence not settle human risk?
Laboratory studies show plausible mechanisms under defined particle types, doses, and durations, but not that ordinary human exposure produces the same effects.
What should people or policymakers do while evidence develops?
They can support proportionate source reduction and occupational safeguards, but no proven treatment or individual dose threshold is established.